drugset / Trial / NCT07640217
A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of SYH2068 injection in patients with elevated lipoprotein(a).
Timeline
- Start
- 2026-07-30
- Primary completion
- 2028-03-30
- Completion
- 2028-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYH2068 | Unknown | — | Subcutaneous |
Indications
No indication recorded.